• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向假定的μ阿片受体和趋化因子受体CXCR4异二聚体的二价探针的设计与合成。

Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimer.

作者信息

Reinecke Bethany A, Kang Guifeng, Zheng Yi, Obeng Samuel, Zhang Huijun, Selley Dana E, An Jing, Zhang Yan

机构信息

Department of Medicinal Chemistry , Virginia Commonwealth University , 800 East Leigh Street , Richmond , VA 23298 , USA . Email:

Department of Medicine , Division of Infectious Diseases , School of Medicine , University of California San Diego , 9500 Gilman Drive, Stein Clinical Research Building, Suite 410 , La Jolla , CA 92093 , USA.

出版信息

RSC Med Chem. 2019 Dec 19;11(1):125-131. doi: 10.1039/c9md00433e. eCollection 2020 Jan 1.

DOI:10.1039/c9md00433e
PMID:33479612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7451026/
Abstract

Opioid abuse and HIV/AIDS have been defined as synergistic epidemics. Opioids can accelerate HIV replication in the immune system by up-regulating the expression of HIV co-receptor CXCR4. Several hypotheses have been suggested as the mechanism of CXCR4 modulation by opioids through their activation on the mu opioid receptor (MOR). One hypothesis is the putative heterodimerization of the MOR and CXCR4 as a mechanism of cross-talk and subsequent exacerbation of HIV replication. Bivalent chemical probes can be powerful molecular tools to characterize protein-protein interactions, and modulate the function related to such interactions. Herein we report the design and synthesis of a novel bivalent probe to explore the putative MOR-CXCR4 dimerization and its potential pharmacological role in enhancing HIV progression. The developed bivalent probe was designed with two distinct pharmacophores linked through a spacer. One pharmacophore (naltrexone) will interact with the MOR and the other (IT1t) with the CXCR4. The overall synthetic routes to prepare the bivalent probe and its corresponding monovalent controls were comprised of 18-22 steps with acceptable yields. Preliminary biological evaluation showed that the bivalent probe preserved binding affinity and functional activity at both respective receptors, supporting the initial molecular design.

摘要

阿片类药物滥用和艾滋病毒/艾滋病已被定义为协同流行疾病。阿片类药物可通过上调艾滋病毒共受体CXCR4的表达来加速免疫系统中的艾滋病毒复制。有人提出了几种假说,作为阿片类药物通过激活μ阿片受体(MOR)来调节CXCR4的机制。一种假说是MOR与CXCR4假定的异源二聚化,作为一种相互作用及随后加剧艾滋病毒复制的机制。二价化学探针可能是表征蛋白质-蛋白质相互作用并调节与此类相互作用相关功能的强大分子工具。在此,我们报告一种新型二价探针的设计与合成,以探索假定的MOR-CXCR4二聚化及其在增强艾滋病毒进展中的潜在药理学作用。所开发的二价探针设计为通过一个间隔基连接的两个不同药效基团。一个药效基团(纳曲酮)将与MOR相互作用,另一个(IT1t)与CXCR4相互作用。制备二价探针及其相应单价对照的总体合成路线包括18-22步,产率尚可。初步生物学评估表明,二价探针在各自的受体上均保留了结合亲和力和功能活性,支持最初的分子设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/19541b3b9d56/c9md00433e-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/5870719021f5/c9md00433e-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/1a823f11ad4b/c9md00433e-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/29a66c0b5e51/c9md00433e-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/aa78fd42a4a0/c9md00433e-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/19541b3b9d56/c9md00433e-s4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/5870719021f5/c9md00433e-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/1a823f11ad4b/c9md00433e-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/29a66c0b5e51/c9md00433e-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/aa78fd42a4a0/c9md00433e-s3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf6e/7451026/19541b3b9d56/c9md00433e-s4.jpg

相似文献

1
Design and synthesis of a bivalent probe targeting the putative mu opioid receptor and chemokine receptor CXCR4 heterodimer.靶向假定的μ阿片受体和趋化因子受体CXCR4异二聚体的二价探针的设计与合成。
RSC Med Chem. 2019 Dec 19;11(1):125-131. doi: 10.1039/c9md00433e. eCollection 2020 Jan 1.
2
Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5.设计并合成一种双价配体以探索μ阿片受体和趋化因子受体 CCR5 假定的异二聚化。
Org Biomol Chem. 2012 Apr 7;10(13):2633-46. doi: 10.1039/c2ob06801j. Epub 2012 Feb 22.
3
Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry.靶向假定的μ阿片受体和趋化因子受体CXCR4二聚体的双价配体在阿片类药物增强HIV-1进入过程中的作用
ACS Med Chem Lett. 2020 Sep 13;11(11):2318-2324. doi: 10.1021/acsmedchemlett.0c00444. eCollection 2020 Nov 12.
4
Novel bivalent ligands carrying potential antinociceptive effects by targeting putative mu opioid receptor and chemokine receptor CXCR4 heterodimers.新型双价配体通过靶向假定的μ阿片受体和趋化因子受体 CXCR4 异二聚体发挥潜在的抗伤害作用。
Bioorg Chem. 2022 Mar;120:105641. doi: 10.1016/j.bioorg.2022.105641. Epub 2022 Jan 24.
5
A Bivalent Ligand Targeting the Putative Mu Opioid Receptor and Chemokine Receptor CCR5 Heterodimers: Binding Affinity versus Functional Activities.一种靶向假定的μ阿片受体和趋化因子受体CCR5异二聚体的双价配体:结合亲和力与功能活性
Medchemcomm. 2013 May 1;4(5):847-851. doi: 10.1039/C3MD00080J.
6
Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.靶向假定的μ阿片受体和趋化因子受体CCR5二聚化的双价配体的研究
Bioorg Med Chem. 2016 Nov 15;24(22):5969-5987. doi: 10.1016/j.bmc.2016.09.059. Epub 2016 Sep 26.
7
Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity.基于结构的设计和开发针对假定 MOR-CCR5 异二聚体的化学探针以抑制阿片类药物增强的 HIV-1 感染性。
J Med Chem. 2021 Jun 10;64(11):7702-7723. doi: 10.1021/acs.jmedchem.1c00408. Epub 2021 May 23.
8
Bivalent ligands targeting chemokine receptor dimerization: molecular design and functional studies.靶向趋化因子受体二聚化的双价配体:分子设计与功能研究
Curr Top Med Chem. 2014;14(13):1606-18. doi: 10.2174/1568026614666140827144752.
9
Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.μ-阿片受体激动剂DAMGO对TF-1人骨髓祖细胞表面CXCR4及HIV-1复制的影响
BMC Res Notes. 2014 Oct 23;7:752. doi: 10.1186/1756-0500-7-752.
10
A bivalent compound targeting CCR5 and the mu opioid receptor treats inflammatory arthritis pain in mice without inducing pharmacologic tolerance.一种同时针对 CCR5 和 μ 阿片受体的双价化合物可治疗小鼠的炎症性关节炎疼痛而不诱导药物耐受。
Arthritis Res Ther. 2018 Jul 27;20(1):154. doi: 10.1186/s13075-018-1661-5.

引用本文的文献

1
Novel bivalent ligands carrying potential antinociceptive effects by targeting putative mu opioid receptor and chemokine receptor CXCR4 heterodimers.新型双价配体通过靶向假定的μ阿片受体和趋化因子受体 CXCR4 异二聚体发挥潜在的抗伤害作用。
Bioorg Chem. 2022 Mar;120:105641. doi: 10.1016/j.bioorg.2022.105641. Epub 2022 Jan 24.
2
Structure-Based Design and Development of Chemical Probes Targeting Putative MOR-CCR5 Heterodimers to Inhibit Opioid Exacerbated HIV-1 Infectivity.基于结构的设计和开发针对假定 MOR-CCR5 异二聚体的化学探针以抑制阿片类药物增强的 HIV-1 感染性。
J Med Chem. 2021 Jun 10;64(11):7702-7723. doi: 10.1021/acs.jmedchem.1c00408. Epub 2021 May 23.
3

本文引用的文献

1
Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.靶向假定的μ阿片受体和趋化因子受体CCR5二聚化的双价配体的研究
Bioorg Med Chem. 2016 Nov 15;24(22):5969-5987. doi: 10.1016/j.bmc.2016.09.059. Epub 2016 Sep 26.
2
Modeling the Effects of Morphine on Simian Immunodeficiency Virus Dynamics.模拟吗啡对猿猴免疫缺陷病毒动力学的影响。
PLoS Comput Biol. 2016 Sep 26;12(9):e1005127. doi: 10.1371/journal.pcbi.1005127. eCollection 2016 Sep.
3
Opioids and Viral Infections: A Double-Edged Sword.
Bivalent Ligand Aiming Putative Mu Opioid Receptor and Chemokine Receptor CXCR4 Dimers in Opioid Enhanced HIV-1 Entry.
靶向假定的μ阿片受体和趋化因子受体CXCR4二聚体的双价配体在阿片类药物增强HIV-1进入过程中的作用
ACS Med Chem Lett. 2020 Sep 13;11(11):2318-2324. doi: 10.1021/acsmedchemlett.0c00444. eCollection 2020 Nov 12.
4
Design of bivalent ligands targeting putative GPCR dimers.双价配体设计针对假定的 G 蛋白偶联受体二聚体。
Drug Discov Today. 2021 Jan;26(1):189-199. doi: 10.1016/j.drudis.2020.10.006. Epub 2020 Oct 16.
阿片类药物与病毒感染:一把双刃剑。
Front Microbiol. 2016 Jun 22;7:970. doi: 10.3389/fmicb.2016.00970. eCollection 2016.
4
Opioid System Modulates the Immune Function: A Review.阿片类系统对免疫功能的调节:综述
Transl Perioper Pain Med. 2016;1(1):5-13.
5
Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5).通过靶向μ阿片受体/趋化因子受体5异聚体(MOR-CCR5)抑制炎性和神经性疼痛
J Med Chem. 2015 Nov 12;58(21):8647-57. doi: 10.1021/acs.jmedchem.5b01245. Epub 2015 Oct 20.
6
Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives.CXCR4趋化因子受体/配体家族的多样性与相互联系:分子视角
Front Immunol. 2015 Aug 21;6:429. doi: 10.3389/fimmu.2015.00429. eCollection 2015.
7
Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.结构生物学。趋化因子受体CXCR4与一种病毒趋化因子复合物的晶体结构。
Science. 2015 Mar 6;347(6226):1117-22. doi: 10.1126/science.1261064. Epub 2015 Jan 22.
8
Opioid and chemokine receptor crosstalk: a promising target for pain therapy?阿片类药物和趋化因子受体相互作用:疼痛治疗的有前途靶点?
Nat Rev Neurosci. 2015 Feb;16(2):69-78. doi: 10.1038/nrn3858. Epub 2015 Jan 15.
9
Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.μ-阿片受体激动剂DAMGO对TF-1人骨髓祖细胞表面CXCR4及HIV-1复制的影响
BMC Res Notes. 2014 Oct 23;7:752. doi: 10.1186/1756-0500-7-752.
10
Functions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-opioid receptors.趋化因子受体CXCR4在中枢神经系统中的功能及其受μ-阿片受体的调节
Int Rev Neurobiol. 2014;118:105-28. doi: 10.1016/B978-0-12-801284-0.00005-1.